Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ: RCKT · IEX Real-Time Price · USD

22.80

-0.68 (-2.90%)

At close: Apr 19, 2024, 4:00 PM

22.81

+0.01 (0.04%)

After-hours: Apr 19, 2024, 4:29 PM EDT

Rocket Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Selling, General & Admin	73.32	58.77	41.77	28.87	18.24	17.89	4.86	1.58	7.84	2.11	Upgrade
Research & Development	186.34	165.57	125.48	105.44	57.91	53.27	14.92	5.99	12.55	5.59	Upgrade
Operating Expenses	259.66	224.34	167.25	134.3	76.15	71.16	19.77	7.57	20.4	7.7	Upgrade
Operating Income	-259.66	-224.34	-167.25	-134.3	-76.15	-71.16	-19.77	-7.57	-20.4	-7.7	Upgrade
Interest Expense / Income	1.88	1.86	2.98	6.97	5.96	6.04	0	0	1.23	0.98	Upgrade
Other Expense / Income	-15.94	-4.34	-1.16	-1.57	-4.84	-2.68	-0.19	-0	46.36	0.85	Upgrade
Pretax Income	-245.6	-221.86	-169.07	-139.7	-77.27	-74.52	-19.58	-7.57	-67.98	-9.53	Upgrade
Net Income	-245.6	-221.86	-169.07	-139.7	-77.27	-74.52	-19.58	-7.57	-67.98	-9.53	Upgrade
Shares Outstanding (Basic)	84	68	63	55	49	39	7	7	5	0	Upgrade
Shares Outstanding (Diluted)	84	68	63	55	49	39	7	7	5	0	Upgrade
Shares Change	23.27%	7.77%	14.18%	13.00%	24.46%	479.46%	-0.56%	49.28%	1695.07%	0.19%	Upgrade
EPS (Basic)	-2.92	-3.26	-2.67	-2.52	-1.58	-1.89	-2.88	-1.11	-14.88	-54.08	Upgrade
EPS (Diluted)	-2.92	-3.26	-2.67	-2.52	-1.58	-1.89	-2.88	-1.11	-14.88	-54.08	Upgrade
Free Cash Flow	-211.39	-186.76	-128.88	-103.7	-87.93	-55.22	-16.72	-5.84	-17.83	-9.74	Upgrade
Free Cash Flow Per Share	-2.52	-2.74	-2.04	-1.87	-1.79	-1.40	-2.46	-0.85	-3.89	-38.20	Upgrade
EBITDA	-236.62	-213.74	-160.72	-126.48	-70.89	-68.15	-19.37	-7.51	-66.71	-8.55	Upgrade
Depreciation & Amortization	7.1	6.27	5.37	6.25	0.43	0.33	0.2	0.07	0.05	0	Upgrade
EBIT	-243.72	-220	-166.09	-132.73	-71.31	-68.48	-19.58	-7.57	-66.75	-8.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).